Disclosures Jastreboff reports consulting for Amgen, AstraZeneca, Biohaven, Boehringer Ingelheim, Eli Lilly, Intellihealth, Novo Nordisk, Pfizer, Rhythm Pharmaceuticals, Scholar Rock, Structure Therapeutics, Terns Pharmaceuticals, Weight Watchers, and Zealand Pharma A/S.
Who should use 5 Amino 1 MQ
Microbial metabolites like SCFA and Trp derivatives can activate AhR and its target genes, including IL-6, IL-22, prostaglandin G/H synthase 2 (PTGS2), vascular endothelial growth factor A (VEGFA), and cytochrome P450 1 A1 (CYP1 A1) in the intestine or liver
Amylin expected to be the next big target Amylin analogs are a different modality (non-incretin) as it works by increasing satiety and increasing leptin sensitivity, which is a distinct mechanism compared to GLP-1
We are located at 601A Professional Drive, Suite 370, Lawrenceville, GA 30046